| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
189,490,000 |
| Market
Cap: |
1.51(B) |
| Last
Volume: |
1,754,233 |
Avg
Vol: |
4,315,920 |
| 52
Week Range: |
$4.13 - $8.69 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1115 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
183,601 |
183,601 |
183,601 |
| Total Buy Value |
$0 |
$1,048,338 |
$1,048,338 |
$1,048,338 |
| Total People Bought |
0 |
10 |
10 |
10 |
| Total Buy Transactions |
0 |
10 |
10 |
10 |
| Total Shares Sold |
0 |
11,387 |
11,387 |
506,586 |
| Total Sell Value |
$0 |
$69,059 |
$69,059 |
$6,068,300 |
| Total People Sold |
0 |
2 |
2 |
10 |
| Total Sell Transactions |
0 |
2 |
2 |
16 |
| End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bennett J Claude |
President |
• • – |
2006-02-13 |
4 |
OE |
$3.59 |
$39,870 |
D/D |
6,167 |
35,005 |
|
- |
|
| Featheringill William W |
Director |
– • – |
2006-02-10 |
4 |
S |
$16.20 |
$267,099 |
I/I |
(16,200) |
925,000 |
|
- |
|
| Riggs Randall B |
officerTitle |
• – – |
2006-01-31 |
4 |
OE |
$6.04 |
$9,125 |
D/D |
1,512 |
1,512 |
|
- |
|
| Gordon Carl L |
officerTitle |
– • – |
2005-12-02 |
4 |
S |
$14.68 |
$8,318,672 |
I/I |
(566,667) |
1,100,000 |
|
- |
|
| Bugg Charles E |
CEO, Chairman |
• • – |
2005-09-26 |
4 |
AS |
$10.00 |
$950,321 |
D/D |
(95,000) |
57,557 |
|
- |
|
| Bugg Charles E |
CEO, Chairman |
• • – |
2005-09-26 |
4 |
OE |
$8.88 |
$887,500 |
D/D |
100,000 |
152,557 |
|
- |
|
| Bennett J Claude |
President |
• • – |
2005-07-13 |
4/A |
OE |
$3.59 |
$13,642 |
D/D |
3,800 |
23,269 |
|
- |
|
| Bennett J Claude |
President |
• • – |
2005-07-13 |
4 |
OE |
$0.87 |
$19,181 |
D/D |
9,369 |
28,838 |
|
- |
|
| Bennett J Claude |
President |
• • – |
2005-02-07 |
4 |
OE |
$0.87 |
$4,348 |
D/D |
2,718 |
19,469 |
|
- |
|
| Spencer William M III |
Director |
– • – |
2004-05-12 |
4 |
OE |
$4.63 |
$115,625 |
D/D |
25,000 |
533,109 |
|
- |
|
| Bugg Charles E |
CEO |
• • – |
2004-04-27 |
4 |
S |
$9.50 |
$808,407 |
D/D |
(85,000) |
52,557 |
|
- |
|
| Bugg Charles E |
CEO |
• • – |
2004-04-27 |
4 |
A |
$4.63 |
$462,500 |
D/D |
100,000 |
137,557 |
|
- |
|
| Darwin Michael A |
CFO |
• – – |
2004-03-12 |
4 |
S |
$8.02 |
$45,533 |
D/D |
(5,650) |
668 |
|
- |
|
| Darwin Michael A |
CFO |
• – – |
2004-03-12 |
4 |
OE |
$0.87 |
$4,949 |
D/D |
5,650 |
6,318 |
|
- |
|
| Darwin Michael A |
CFO |
• – – |
2004-01-30 |
4 |
OE |
$3.39 |
$2,266 |
D/D |
668 |
668 |
|
- |
|
| Horovitz Zola P |
Director |
– • – |
2003-11-14 |
4 |
S |
$8.20 |
$93,490 |
D/D |
(11,300) |
3,000 |
|
- |
|
| Horovitz Zola P |
Director |
– • – |
2003-11-13 |
4 |
S |
$8.25 |
$89,045 |
D/D |
(10,700) |
14,300 |
|
- |
|
| Horovitz Zola P |
Director |
– • – |
2003-11-06 |
4 |
OE |
$4.63 |
$115,625 |
D/D |
25,000 |
25,000 |
|
- |
|
| Montgomery John A |
Director |
– • – |
2003-11-04 |
4 |
S |
$8.50 |
$340,000 |
D/D |
(40,000) |
46,785 |
|
- |
|
| Montgomery John A |
Director |
– • – |
2003-11-04 |
4 |
OE |
$6.00 |
$240,000 |
D/D |
40,000 |
86,785 |
|
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2003-10-27 |
4 |
S |
$8.00 |
$5,968,000 |
I/I |
(746,000) |
1,455,900 |
|
- |
|
| Bugg Charles E |
CEO |
• • – |
2003-10-24 |
4/A |
OE |
$6.00 |
$60,000 |
D/D |
10,000 |
37,557 |
|
- |
|
| Bugg Charles E |
CEO |
• • – |
2003-10-24 |
4 |
OE |
$6.00 |
$60,000 |
D/D |
10,000 |
44,035 |
|
- |
|
| Bugg Charles E |
CEO |
• • – |
2003-09-12 |
4/A |
GD |
$0.00 |
$0 |
D/D |
6,478 |
27,557 |
|
- |
|
| Sherrill Joseph H Jr |
Director |
– • – |
2003-08-07 |
4 |
B |
$4.75 |
$33,270 |
D/D |
7,000 |
492,000 |
2.39 |
- |
|
755 Records found
|
|
Page 30 of 31 |
|
|
